Cita APA (7a ed.)

Lyskjær, I., Davies, C., Strobl, A., Hindley, J., James, S., Lalam, R. K., . . . Flanagan, A. M. (2021). Circulating tumour DNA is a promising biomarker for risk stratification of central chondrosarcoma with IDH1/2 and GNAS mutations. Wiley.

Cita Chicago Style (17a ed.)

Lyskjær, Iben, et al. Circulating Tumour DNA Is a Promising Biomarker for Risk Stratification of Central Chondrosarcoma with IDH1/2 and GNAS Mutations. Wiley, 2021.

Cita MLA (8a ed.)

Lyskjær, Iben, et al. Circulating Tumour DNA Is a Promising Biomarker for Risk Stratification of Central Chondrosarcoma with IDH1/2 and GNAS Mutations. Wiley, 2021.